Allevate - Ketamine Therapy Princeton
707 State Road, Suite 105, Princeton
5.0(10 Google reviews)

Independent national directory · 550 cities
A national directory of certified Spravato (esketamine) treatment centers, with plain-language guides on cost, insurance, and what to expect.
2178
Verified US listings
48
States covered
REMS
Certified-setting treatment
2+ hrs
Monitoring after each dose
Provider directory
Compare clinic locations, insurance information, REMS certification status when verified, and direct contact details.
707 State Road, Suite 105, Princeton
5.0(10 Google reviews)
1270 New Jersey 35, Suite 4, Middletown Township
5.0(6 Google reviews)
308 South Friendswood Drive, Suite 200, Friendswood
4.8(5977 Google reviews)
3033 North Central Avenue, Suite 700, Phoenix
4.8(2714 Google reviews)
4750 South Garnett Road, Tulsa
4.8(2667 Google reviews)
441 South Livernois Road, 100, Rochester Hills
4.7(1980 Google reviews)
Getting started
Three steps, no referral needed in most cases. Here is what the path from searching to your first session actually looks like.
Search by city or ZIP and compare verified location, contact, insurance, and REMS details.
Call the practice directly or send one short request and we pass it straight to clinics taking new patients.
A qualified healthcare professional determines whether SPRAVATO® is appropriate, reviews safety risks, and discusses an individualized schedule.

What SPRAVATO® is
SPRAVATO® is esketamine nasal spray. A healthcare professional supervises self-administration in a certified treatment setting.
Coverage and prior-authorization rules vary by diagnosis, plan, benefit design, and treatment center. Confirm benefits before treatment.
The clinic monitors you for at least two hours after administration. You must arrange transportation and not drive until the next day after restful sleep.

By condition
Our guides separate the two adult indications from broader depression education and explain important limitations.
SPRAVATO® (esketamine) nasal spray is FDA-approved for adults with treatment-resistant depression — depression that has not improved after at least two antidepressants, used alone or with an oral antidepressant.
Read moreSPRAVATO® is FDA-approved, together with an oral antidepressant, for adults with major depressive disorder who have acute suicidal ideation or behavior — as part of urgent, supervised care.
Read moreBrowse by location
Every visit requires in-clinic dosing, monitoring, and transportation home, so location matters.
Resource hub
Insurance & cost
Most large U.S. health plans publish a coverage policy for SPRAVATO®. Here is what those policies commonly require, and how to check your own plan.
September 28, 2026 · 5 min read
Understanding SPRAVATO®
What SPRAVATO® is, the two adult uses the FDA has approved, and how it differs from a pill you take at home.
September 28, 2026 · 3 min read
Treatment journey
Before, during, and after a monitored treatment session — including the two-hour observation and why you need a ride home.
September 28, 2026 · 3 min read
Free, no obligation
Share your town and your insurance. We match you with providers who treat your condition, accept your plan, and are actually taking new patients.
News desk
Insurance & cost
SPRAVATO® is usually billed under Medicare Part B. Here is what original Medicare, Medicare Advantage, and Medigap can mean for your cost — and the questions to ask.
Treatment updates
The TRANSFORM, SUSTAIN, and ASPIRE studies established SPRAVATO®'s approvals. Here is what the evidence supports — and where it stops.
Treatment updates
The January 2025 prescribing information lists SPRAVATO® for adult TRD either as monotherapy or with an oral antidepressant.